- Home
- TLSA vs FINW Comparison
TLSA vs FINW Comparison
Compare TLSA & FINW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- FINW
- Stock Information
- Founded
- TLSA 2013
- FINW 1999
- Country
- TLSA United Kingdom
- FINW United States
- Employees
- TLSA N/A
- FINW N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- FINW Commercial Banks
- Sector
- TLSA Health Care
- FINW Finance
- Exchange
- TLSA Nasdaq
- FINW Nasdaq
- Market Cap
- TLSA 175.3M
- FINW 196.2M
- IPO Year
- TLSA 2000
- FINW 2021
- Fundamental
- Price
- TLSA $1.42
- FINW $14.20
- Analyst Decision
- TLSA
- FINW Buy
- Analyst Count
- TLSA 0
- FINW 4
- Target Price
- TLSA N/A
- FINW $20.75
- AVG Volume (30 Days)
- TLSA 473.1K
- FINW 17.1K
- Earning Date
- TLSA 06-10-2025
- FINW 07-24-2025
- Dividend Yield
- TLSA N/A
- FINW N/A
- EPS Growth
- TLSA N/A
- FINW N/A
- EPS
- TLSA N/A
- FINW 0.91
- Revenue
- TLSA N/A
- FINW $72,056,000.00
- Revenue This Year
- TLSA N/A
- FINW $39.19
- Revenue Next Year
- TLSA N/A
- FINW $19.14
- P/E Ratio
- TLSA N/A
- FINW $15.68
- Revenue Growth
- TLSA N/A
- FINW 8.59
- 52 Week Low
- TLSA $0.63
- FINW $10.10
- 52 Week High
- TLSA $1.91
- FINW $20.94
- Technical
- Relative Strength Index (RSI)
- TLSA 52.03
- FINW 40.21
- Support Level
- TLSA $1.30
- FINW $14.16
- Resistance Level
- TLSA $1.68
- FINW $14.96
- Average True Range (ATR)
- TLSA 0.15
- FINW 0.57
- MACD
- TLSA -0.02
- FINW -0.02
- Stochastic Oscillator
- TLSA 31.58
- FINW 4.69
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About FINW FinWise Bancorp
FinWise Bancorp is an independent bank that provides a full range of banking services to individual and corporate customers. The bank's primary source of revenue is from loans, including Small Business Administration, commercial, commercial real estate, residential real estate, and consumer. The Bank has also established Strategic Programs with various third-party loan origination platforms that use technology to streamline the origination of unsecured consumer and secured or unsecured business loans to borrowers within certain approved credit profiles.